Racial disparities in multiple myeloma
Multiple myeloma (MM) is the leading lymphoid malignancy with significant racial disparities, stemming from disparities in disease epidemiology, disease biology, treatment utilization and survival. In this review, we highlight important areas of disparities between Black (African descent) and White (European descent) MM patients by summarizing available evidence and suggesting methods to bridge the gap.
Authors
- Leo Rasche (ORCID: https://orcid.org/0000-0002-9536-9649)
- Peter Rambau (ORCID: https://orcid.org/0000-0001-5875-6343)
- Erius Tebuka (ORCID: https://orcid.org/0000-0002-9821-3260)
Institutions
- Catholic University of Health and Allied Sciences (TZ)
- Universitätsklinikum Würzburg (DE)
Publication Details
- Journal
- Blood Global Hematology
- Published
- 2025-07-05
- DOI
- https://doi.org/10.1016/j.bglo.2025.100017
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00